Plasmablastic lymphoma

Last revised by Yuranga Weerakkody on 29 Apr 2022

Plasmablastic lymphoma (PbL) is a type of rare and aggressive B-cell malignancy (considered a type of non-Hodgkin lymphoma). 

It usually comprises of large neoplastic cells, most of them resembling plasmablasts that have a CD20-negative phenotype.

Although initially described as being associated with HIV, over the years it has also been identified in patients with solid organ transplant and immunocompetent patients.

It is generally also associated with Epstein-Barr virus and HHV-8 infections and frequently involves the oral cavity 6

It usually has an aggressive behavior and is refractory to chemotherapy with a poor prognosis in many patients.

It was first described in 1997 by Delecluse et al in patients with HIV.

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.